Thrombosis Research in Advanced Disease (TRAD) Alliance
“A global approach to thrombosis research”
July 2011: TRAD at the COMET Conference
The TRAD Alliance had a poster at the Core Outcome Measures for Effectiveness Trials conference in Bristol in July. This is a developing initiative to focus on ensuring agreed measures are use across a domain to facilitate the use of evidence. Input is needed from all stakeholders and there are a number of different methodological approaches used to combine views. Further details on the initiative can be found on http://www.comet-initiative.org/.
The poster from TRAD focussed on the need for an agreed outcome set for thrombosis in advanced disease and put the case for this being distinct from thrombosis research in cancer. Some interest was shown in the poster, particularly from the Cochrane Consumers and Communication Review group (http://www.latrobe.edu.au/chcp/cochrane/).
April 2011: Presentation to Bristol SPRs
Simon Noble was invited on the 13th of April to speak on thromboprophylaxis in the palliative care setting to trainees from the South West. The talk is accessible below (will open in a new window):
March 2011: Leeds Presentation
Dr Simon Noble and Anthony Maraveyas spoke to haematologists and thrombosis colleagues at a regional meeting in Leeds on the 9th of March.
To view the presentations click on the following links (will open in a new window):
February 2011: Academic Recognitions for TRAD Alliance Co-Directors
Congratulations to our co-directors Dr Miriam Johnson and Dr Anthony Maraveyas on being promoted to the academic positions of Reader in Palliative Medicine and Oncology respectively. This is in recognition of their many academic achievements, not least being their contribution to research into VTE in oncology and advanced disease.
November 2010: Thank you For Attending the TRAD Conference
The TRAD Alliance hosted The Inaugural Thrombosis Research in Advanced Disease Alliance Scientific Meeting on the 24th of November 2010 at Holland House Hotel, Cardiff, Wales. We thank all those who attended the Conference for making it such a success and for contributing throughout the day. Information regarding the Conference can be viewed here or through the above TRAD Events Tab, including presentations and photos.
November 2010: Expert Group Convened for Roundtable Discussion
One day prior to its inaugural scientific meeting in Cardiff, the TRAD Alliance will host an Experts roundtable meeting to critically appraise the current evidence informing the prevention and management of experts VTE in advanced cancer. Bringing together professionals from haematology, oncology, palliative and primary care, this multidisciplinary group from fields such as medicine, nursing, pharmacy and clinical psychology will also identify key priorities for future VTE research within the palliative care setting.
October 2010: The TRAD Alliance Reaches Membership of 100.
With only a few days to go before the inaugural scientific meeting of the TRAD Alliance in Cardiff, we are delighted to announce the number of people signed up as TRAD Allies has exceeded 100 professionals from seven countries. This exciting news reaffirms the philosophy of the organisation that by taking a global approach to thrombosis research and through collaborative working we will be better equipped to tackle the challenges faced by patients with VTE and advanced disease.
June 2010: Thromboprophylaxis Audit Presented at European Association of Palliative Care Scientific Meeting in Glasgow
The results of a multicentre audit of hospice patients and the thrombotic risk were presented at this international meeting as an oral presentation. The success of the work highlights the need for collaborative work and recruitment between palliative care teams and underpins the mission of the TRAD Alliance.
To view the presentation click on the following link (will open in a new window):
May 2010: Presentation at the Institute of Physics
The current issues in Palliative Care Meeting, hosted by the International Journal of Palliative Nursing and Hospital Medicine was held at the Institute of Physics on the 6th and 7th May. Simon Noble presented a talk entitled “Thromboprophylaxis: Risks and Benefits”, which can be viewed here (will open in a new window):
April 2010: Presentation at the International Thrombosis and Haemostasis Issues in Cancer Conference, Stresa Italy
Despite travel interruptions due to volcanic ash, the International Thrombosis and Haemostasis Issues in Cancer Conference went ahead at Stresa Italy. TRAD Alliance medical director Anthony Maraveyas gave an oral presentation on “Gemcitabine with or without prophylactic weight-adjusted dalteparin (WAD) in patients with advanced or metastatic pancreatic cancer (APC): a multicentre, randomised phase IIB trial (the UK FRAGEM study)”.
Also, a poster presentation titled “Filling the evidence gap in palliative care: a qualitative study to identify the research agenda for thromboprophylaxis in advanced cancer” by S.I.R. Noble, A. Nelson, I.G. Finlay was presented on behalf of the TRAD Alliance.
An abstract of the poster can be viewed from the following link (will open in a new window):
March 2010: TRAD Alliance Launch at the Palliative Care Congress in Bournemouth
The TRAD Alliance was launched at the Palliative Care Congress in Bournemouth on March the 12th as part of the Masterclass in Venous thromboembolism (VTE). The session, chaired by Dr Bill Noble (Immediate Past Chair of the APM) heard presentations from Miriam Johnson and Simon Noble about the challenges of treating and preventing VTE in the palliative care setting.
Presentations included an overview of current evidence, research opportunities in the field and the current work of the TRAD Alliance.
To view the presentations click on the following links (will open in a new window):
